Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Functional enrichment: significant results.BMI and COVIDPOPTermp-valueq-valuenumber of overlapped genesgenesGO biological processProtein N-linked Glycosylation (GO:0006487)0.000210.014272/64KRTCAP2;SLC39A8Regulation of RNA Biosynthetic Process (GO:2001141)0.000410.014273/465ZNF536;SLC39A8;LIMD1Protein Glycosylation (GO:0006486)0.001070.024982/145KRTCAP2;SLC39A8Osteoblast Development (GO:0002076)0.002100.028081/6LIMD1Manganese Ion Transport (GO:0006828)0.002800.028081/8SLC39A8Zinc Ion Import Across Plasma Membrane (GO:0071578)0.002800.028081/8SLC39A8Regulation of DNA-templated Transcription (GO:0006355)0.003500.028084/2139MED24;ZNF536;SLC39A8;LIMD1Arginine Metabolic Process (GO:0006525)0.003840.028081/11SLC39A8Iron Ion Transmembrane Transport (GO:0034755)0.003840.028081/11SLC39A8Negative Regulation of Intracellular Signal Transduction (GO:1902532)0.004390.028082/297SLC39A8;LIMD1P-body Assembly (GO:0033962)0.004540.028081/13LIMD1Regulation of Gene Expression (GO:0010468)0.005260.028083/1127ZNF536;SLC39A8;LIMD1Cellular Response to Cadmium Ion (GO:0071276)0.005940.028081/17SLC39A8miRNA-mediated Gene Silencing by Inhibition of Translation (GO:0035278)0.005940.028081/17LIMD1Intracellular Monoatomic Ion Homeostasis (GO:0006873)0.006280.028081/18SLC39A8Leukocyte Adhesion to Vascular Endothelial Cell (GO:0061756)0.006630.028081/19SLC39A8Bicarbonate Transport (GO:0015701)0.006980.028081/20SLC39A8Regulatory ncRNA-mediated Post-Transcriptional Gene Silencing (GO:0035194)0.008020.028081/23LIMD1Negative Regulation of Hippo Signaling (GO:0035331)0.008020.028081/23LIMD1Zinc Ion Transmembrane Transport (GO:0071577)0.008020.028081/23SLC39A8Zinc Ion Transport (GO:0006829)0.008720.028651/25SLC39A8miRNA-mediated Post-Transcriptional Gene Silencing (GO:0035195)0.009410.028651/27LIMD1Alpha-Amino Acid Metabolic Process (GO:1901605)0.009410.028651/27SLC39A8Intracellular Zinc Ion Homeostasis (GO:0006882)0.010110.029481/29SLC39A8Transition Metal Ion Transport (GO:0000041)0.010800.030241/31SLC39A8Negative Regulation of Osteoblast Differentiation (GO:0045668)0.012190.032811/35LIMD1Protein N-linked Glycosylation via Asparagine (GO:0018279)0.012880.033391/37KRTCAP2Regulation of Hippo Signaling (GO:0035330)0.014260.035661/41LIMD1Positive Regulation of Transcription Elongation by RNA Polymerase II (GO:0032968)0.015990.038601/46MED24Positive Regulation of Transcription Initiation by RNA Polymerase II (GO:0060261)0.018750.042321/54MED24Positive Regulation of DNA-templated Transcription, Elongation (GO:0032786)0.018750.042321/54MED24Positive Regulation of DNA-templated Transcription Initiation (GO:2000144)0.020470.042321/59MED24Regulation of Transcription Initiation by RNA Polymerase II (GO:0060260)0.020470.042321/59MED24RNA Polymerase II Preinitiation Complex Assembly (GO:0051123)0.020810.042321/60MED24Negative Regulation of Canonical NF-kappaB Signal Transduction (GO:0043124)0.021160.042321/61SLC39A8Transcription Preinitiation Complex Assembly (GO:0070897)0.021850.042481/63MED24GO molecular functionSolute:Monoatomic Cation Symporter Activity (GO:0015294)0.003500.018131/10SLC39A8Monoatomic Cation:Bicarbonate Symporter Activity (GO:0140410)0.004190.018131/12SLC39A8Nuclear Vitamin D Receptor Binding (GO:0042809)0.004540.018131/13MED24Bicarbonate Transmembrane Transporter Activity (GO:0015106)0.008020.018131/23SLC39A8Zinc Ion Transmembrane Transporter Activity (GO:0005385)0.008370.018131/24SLC39A8Nuclear Thyroid Hormone Receptor Binding (GO:0046966)0.009070.018131/26MED24Transition Metal Ion Transmembrane Transporter Activity (GO:0046915)0.012190.020891/35SLC39A8BMI and SEVPOPGO biological processNegative Regulation of Androgen Receptor Signaling Pathway (GO:0060766)0.000080.015542/14NCOR1;ZBTB7ARegulation of Androgen Receptor Signaling Pathway (GO:0060765)0.000380.026192/29NCOR1;ZBTB7ANegative Regulation of Intracellular Steroid Hormone Receptor Signaling Pathway (GO:0033144)0.000430.026192/31NCOR1;ZBTB7ARegulation of Glycolytic Process (GO:0006110)0.000800.036142/42NCOR1;ZBTB7AGO Cellular ComponentMicrotubule (GO:0005874)0.000910.029933/194MACF1;MAP2K2;BCL2L11Polymeric Cytoskeletal Fiber (GO:0099513)0.002590.042803/280MACF1;MAP2K2;BCL2L11
Source: Results. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Common genetic mechanisms between obesity and COVID-19 severity: unravelling pleiotropic loci and biological pathways
Study design awaiting verification · Royal Society Open Science · 2026
Original publication title
Common genetic mechanisms between obesity and COVID-19 severity: unravelling pleiotropic loci and biological pathways
© 2026 The Authors.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
Abstract
COVID-19 and obesity are complex conditions marked by immune and metabolic dysfunction, with the former still ranking among the leading causes of death from infectious diseases worldwide and the latter reaching pandemic proportions. Clinical evidence consistently shows that obesity increases the risk of severe COVID-19, yet the biological mechanisms underlying this association remain unclear. Given their physiological and clinical overlap, they may share genetic pathways. We investigated genetic variants jointly associated with body mass index (BMI) and COVID-19 using publicly available genome-wide data.
A conjunctional false discovery rate (conjFDR) approach identified shared variants between BMI and three COVID-19 phenotypes: infection, hospitalization and very severe respiratory illness. Functional annotation and pathway enrichment analyses were performed to explore the biological context of these variants, followed by a phenome-wide association study (PheWAS) to characterize pleiotropy. Shared variants were enriched in immune, metabolic and hormonal signaling pathways, including metal ion transport and glycosylation. The overlap with BMI was strongest for hospitalized and severe cases, suggesting common mechanisms underlying disease progression rather than infection.
These findings suggest a biologically meaningful genetic overlap between obesity and COVID-19 severity, highlighting pleiotropy as a key feature in complex disease interactions and potential shared therapeutic targets.
Authors’ abstract
Abstract
COVID-19 and obesity are complex conditions marked by immune and metabolic dysfunction, with the former still ranking among the leading causes of death from infectious diseases worldwide and the latter reaching pandemic proportions. Clinical evidence consistently shows that obesity increases the risk of severe COVID-19, yet the biological mechanisms underlying this association remain unclear. Given their physiological and clinical overlap, they may share genetic pathways. We investigated genetic variants jointly associated with body mass index (BMI) and COVID-19 using publicly available genome-wide data.
A conjunctional false discovery rate (conjFDR) approach identified shared variants between BMI and three COVID-19 phenotypes: infection, hospitalization and very severe respiratory illness. Functional annotation and pathway enrichment analyses were performed to explore the biological context of these variants, followed by a phenome-wide association study (PheWAS) to characterize pleiotropy. Shared variants were enriched in immune, metabolic and hormonal signaling pathways, including metal ion transport and glycosylation. The overlap with BMI was strongest for hospitalized and severe cases, suggesting common mechanisms underlying disease progression rather than infection.
These findings suggest a biologically meaningful genetic overlap between obesity and COVID-19 severity, highlighting pleiotropy as a key feature in complex disease interactions and potential shared therapeutic targets.
Publication and source details
Original title: Common genetic mechanisms between obesity and COVID-19 severity: unravelling pleiotropic loci and biological pathways
Giulia Souza da Costa; Cibele E. Bandeira; Nicolas Pereira Ciochetti; Isabella F. Temoteo; Bianca Rodrigues Martinello; Thais Martins-Silva; Raissa Nunes Dos Santos; Diego L. Rovaris; Marilu Fiegenbaum; Lucia Campos Pellanda; Luciana Tovo-Rodrigues; Júlia Pasqualini Genro
Royal Society Open Science · 2026
Author for correspondence: Júlia Pasqualini Genro e-mail: juliag@ufcspa.edu.brThese authors contributed equally to this study.
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T21:55:31.161994+00:00
DOI: 10.1098/rsos.252355 · PMC13483759